Clinical Trial: A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation (US Fed News Service, Including US State News, 2023)
Keywords: Cholangiocarcinoma; Metastasis; Mutation